• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next
  • expand A Phase I, Open-label, Single-Centre Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration to Healthy Male Subjects
    Study Id
    D6702C00030
    Disease
    depressive disorder
    Drug Name
    AZD6765
    Study Name
    D6702C00030
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Epidemiological, Observational Study to Describe Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease (GERD)
    Study Id
    NIS-GBA-DUM-2010/1
    Study Name
    NIS-GBA-DUM-2010/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A retrospective, medical record study to investigate the current situation of biopsy testing in the Swedish inoperable Non Small Cell Lung Cancer patient population.
    Study Id
    NIS-OSE-DUM-2010/1
    Disease
    non-small cell lung cancer
    Study Name
    NIS-OSE-DUM-2010/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An NIS Registry for the Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic NSCLC (Stage IIIB/IV Non-small Cell Lung Cancer)
    Study Id
    NIS-OGR-DUM-2010/1
    Disease
    non-small cell lung cancer
    Study Name
    NIS-OGR-DUM-2010/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Iressa Follow-up Trial
    Study Id
    1839IL/0555
    Disease
    cancer
    Drug Name
    IRESSA
    Study Name
    1839IL/0555
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine Headache in Adolescents
    Study Id
    D1220C00001
    Disease
    migraine
    Drug Name
    Zomig nasal spray
    Study Name
    D1220C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand National Survey on GERD Patients (Adults and Children)
    Study Id
    NIS-GFR-DUM-2008/2
    Disease
    acid reflux
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    NIS-GFR-DUM-2008/2
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report
    Sep 14, 2010
    • NIS-GFR-DUM-2008_2.pdf (259 KB)
  • expand A Phase I, Double-blind, Randomized, Placebo-controlled', Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD5213 After Administration of Multiple Ascending Doses for 10 Days in Healthy Male and Non-fertile Female Volunteers
    Study Id
    D3030C00002
    Study Name
    D3030C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Comparing Efficacy between Anti-microtubule and Non-anti-microtubule as 3th Therapy after 2nd line EGFR-TKI therapy
    Study Id
    NIS-OTW-DUM-2008/1
    Disease
    lung cancer
    Drug Name
    IRESSA
    Study Name
    NIS-OTW-DUM-2008/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand InPractice Survey on the treatment of hypercholesterolemia
    Study Id
    VN-NIS-0001
    Disease
    hypercholesterolaemia, diabetes type 2, dyslipidaemia
    Drug Name
    Crestor
    Study Name
    VN-NIS-0001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013